- Home
- NWE vs VKTX Comparison
NWE vs VKTX Comparison
Compare NWE & VKTX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- NWE
- VKTX
- Stock Information
- Founded
- NWE 1923
- VKTX 2012
- Country
- NWE United States
- VKTX United States
- Employees
- NWE N/A
- VKTX N/A
- Industry
- NWE Power Generation
- VKTX Biotechnology: Pharmaceutical Preparations
- Sector
- NWE Utilities
- VKTX Health Care
- Exchange
- NWE Nasdaq
- VKTX Nasdaq
- Market Cap
- NWE 3.4B
- VKTX 3.4B
- IPO Year
- NWE N/A
- VKTX 2015
- Fundamental
- Price
- NWE $58.77
- VKTX $23.94
- Analyst Decision
- NWE Buy
- VKTX Strong Buy
- Analyst Count
- NWE 6
- VKTX 12
- Target Price
- NWE $59.42
- VKTX $89.75
- AVG Volume (30 Days)
- NWE 640.9K
- VKTX 4.5M
- Earning Date
- NWE 04-29-2025
- VKTX 04-23-2025
- Dividend Yield
- NWE 4.49%
- VKTX N/A
- EPS Growth
- NWE 13.41
- VKTX N/A
- EPS
- NWE 3.65
- VKTX N/A
- Revenue
- NWE $1,513,898,000.00
- VKTX N/A
- Revenue This Year
- NWE $5.89
- VKTX N/A
- Revenue Next Year
- NWE $4.37
- VKTX N/A
- P/E Ratio
- NWE $16.10
- VKTX N/A
- Revenue Growth
- NWE 6.45
- VKTX N/A
- 52 Week Low
- NWE $47.80
- VKTX $18.92
- 52 Week High
- NWE $59.52
- VKTX $81.86
- Technical
- Relative Strength Index (RSI)
- NWE 63.45
- VKTX 46.06
- Support Level
- NWE $53.46
- VKTX $18.92
- Resistance Level
- NWE $56.85
- VKTX $27.09
- Average True Range (ATR)
- NWE 1.64
- VKTX 2.31
- MACD
- NWE 0.14
- VKTX 0.26
- Stochastic Oscillator
- NWE 87.62
- VKTX 61.44
About NWE NorthWestern Energy Group Inc.
NorthWestern Energy Group Inc provides electricity and natural gas services in the Upper Midwest and Northwest of the U.S. in the states of Montana, South Dakota, Nebraska, and Yellowstone National Park. The company's primary segments include Electric utility operations, which include the generation, purchase, transmission, and distribution of electricity, and Natural Gas utility operations, which include the production, purchase, transmission, storage, and distribution of natural gas. The company uses thermal, wind, hydro, or renewable energy in varying quantities, depending on the location of the facilities, to generate power. The company derives the majority of its revenue from the Electric utility operations segment.
About VKTX Viking Therapeutics Inc.
Viking Therapeutics Inc is a healthcare service provider. The company specializes in the area of biopharmaceutical development focused on metabolic and endocrine disorders. The company's clinical program pipeline consists of VK2809, VK5211, VK0214 products. VK2809 and VK0214 are orally available, tissue and receptor-subtype selective agonists of the thyroid hormone receptor beta. VK5211 is an orally available, non-steroidal selective androgen receptor modulator.